Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacoeconomics: disease-based management applications.

J C Garrelts1

  • 1Via Christi-St. Francis, Wichita, KS 67214, USA.

Pharmacy Practice Management Quarterly
|June 6, 1996
PubMed
Summary

Pharmacoeconomic studies are crucial for comparing treatments and informing formulary decisions. Understanding potential pitfalls in these evaluations is essential for accurate real-world drug assessments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Automated medication distribution systems and compliance with Joint Commission standards.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2002
Same author

The pharmacokinetics, safety, and tolerance of cefepime administered as an intravenous bolus or as a rapid infusion.

The Annals of pharmacotherapy·2000
Same author

Cost-effective treatment of lower respiratory tract infections.

PharmacoEconomics·1996
Same author

Ciprofloxacin pharmacokinetics in burn patients.

Antimicrobial agents and chemotherapy·1996
Same author

Exploration of once-daily dosing of aminoglycosides through Bayesian simulation.

Pharmacotherapy·1996
Same author

Rebound of plasma free phenytoin concentration following plasmapheresisin a patient with thrombotic thrombocytopenic purpura.

The Annals of pharmacotherapy·1995

Area of Science:

  • Health Economics
  • Pharmaceutical Policy
  • Clinical Outcomes Research

Background:

  • Pharmacoeconomic information is increasingly vital for evaluating and comparing medical treatments.
  • It serves as a supplement or alternative to traditional methods for drug formulary inclusion.
  • Real-world drug use and outcomes can significantly differ from clinical trial settings.

Purpose of the Study:

  • To highlight the growing importance of pharmacoeconomic data in healthcare decision-making.
  • To emphasize the need for critical evaluation of pharmacoeconomic study methodologies.
  • To underscore the relevance of pharmacoeconomics in bridging clinical trial findings with real-world application.

Main Methods:

  • Review of current practices in pharmacoeconomic study evaluation.
  • Analysis of the role of pharmacoeconomics in formulary management.
  • Discussion of methodologies for assessing pharmacoeconomic data quality.

Main Results:

  • Pharmacoeconomic data is a key component in modern treatment option assessment.
  • Standard evaluation methods may be supplemented or replaced by pharmacoeconomic information.
  • Recognizing and mitigating methodological pitfalls in pharmacoeconomic studies is critical.

Conclusions:

  • Pharmacoeconomic evaluations are essential for informed treatment choices.
  • Careful consideration of study design and data interpretation is necessary.
  • Bridging the gap between clinical trials and real-world effectiveness relies on robust pharmacoeconomic analysis.

Related Experiment Videos